KIF11: A potential prognostic biomarker for predicting bone metastasis‑free survival of prostate cancer
Authors:
Open Access
- 15 July 2022
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 24 (3) , 1-14
Abstract
Most prostate cancer (PCa) cases remain indolent with a relatively good prognosis. However, bone metastasis of PCa can quickly worsen prognoses and lead to mortality. Metastasis‑free survival (MFS), a strong surrogate for overall survival, is widely used in PCa prognosis research. The present study identified molecules that affect bone MFS in PCa, with clinical validation. Three datasets (GSE32269, GSE74367 and GSE77930) were downloaded from the Gene Expression Omnibus database. Hub genes most relevant to clinical traits (bone metastasis‑associated morbidity) were identified by weighted gene co‑expression network analysis (WGCNA) and subjected to logistic regression analysis. Patient samples were obtained between January 2014 and December 2016, with a clinically annotated follow‑up in December 2021. Clinical data and follow‑up information for 60 patients with PCa were used in MFS analysis. Tumor samples were retrieved, and immunohistochemistry was performed to detect vascular endothelial growth factor (VEGF). The prognostic potential of the two molecules was assessed using Cox proportional hazards regression analysis. A total of 16 gene modules were obtained via WGCNA, and the tan module, containing 147 genes, was most closely linked to bone metastasis. In total, 877 differentially expressed genes (DEGs) were detected. The DEG‑tan module intersection yielded seven hub genes [BUB1, kinesin family member (KIF)2C, RACGAP1, CENPE, KIF11, TTK and KIF20A]. Using univariate and multivariate logistic regression analyses for independent risk factors of bone metastasis, KIF11 and VEGF were found to be significantly associated with a higher T stage, prostate‑specific antigen level and Gleason score. In addition, KIF11 and VEGF expression levels were positively correlated (P<0.001). Using univariate Cox analysis, KIF11 and VEGF were found to exhibit a significant association with poor MFS (P<0.05). However, only KIF11 was significantly associated with MFS upon multivariate analysis (P=0.007; hazard ratio, 2.776; 95% confidence interval, 1.315‑5.859). Markers of bone metastasis in PCa were identified. Overall, KIF11 is an independent indicator that can predict bone metastasis for patients with PCa, which could be used to guide clinical practice.Keywords
This publication has 37 references indexed in Scilit:
- Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancerThe Prostate, 2016
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancerNature Medicine, 2016
- The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic CarcinomaAmerican Journal of Surgical Pathology, 2016
- Mitotic Kinesin Eg5 Overcomes Inhibition to the Phase I/II Clinical Candidate SB743921 by an Allosteric Resistance MechanismJournal of Medicinal Chemistry, 2013
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancerJournal of Clinical Investigation, 2013
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Biomarkers of angiogenesis and their role in the development of VEGF inhibitorsBritish Journal of Cancer, 2009
- Myosin IIA regulates cell motility and actomyosin–microtubule crosstalkNature Cell Biology, 2007
- VEGF as a Therapeutic Target in CancerOncology, 2005
- Microvessel density in prostate carcinomaProstate Cancer and Prostatic Diseases, 2002